Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Hemorrhage × Rivaroxaban × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 2 Venous Thrombosis 1 Venous Thromboembolism 1 Upper Extremity Deep Vein Thrombosis 1 Recurrence 1 Lung Neoplasms 1 Hemorrhage 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Tranexamic Acid 2 Misoprostol 2 carbetocin 1 Vitamin B 6 1 Vasopressins 1 Uterine Artery Embolization 1 Tourniquets 1 Terlipressin 1 Sodium Chloride 1 Sensitivity Training Groups 1 Rivaroxaban 1 Oxytocin 1 Ibuprofen 1 Ethamsylate 1 Enoxaparin 1 Dalteparin 1 Bupivacaine 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01989845 2017-01-09

Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer

Seoul National University Hospital

Phase 4 Completed

Hemorrhage, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡